(icTV) HOT TOPICS RESULTS ~ The ANDROMEDA shock study

(icTV) HOT TOPICS RESULTS The ANDROMEDA shock study Glenn Hernandez (Santiago, Chile) sat down with icTV to discuss the ANDROMEDA shock study which examined peripheral perfusion targeted resuscitation in early septic shock. Results of this trial were presented in the Hot Topics session at LIVES 2018. Watch the full presentation here. #LIVES2018 […]

Read More…

(icTV) CLINICAL TRIALS RESULTS ~ Plasma angiopoietin-2 & ARDS risk in sepsis

(icTV) CLINICAL TRIALS RESULTS Plasma angiopoietin-2 & ARDS risk in sepsis In this icTV interview, presenter John Reilly discusses his clinical trial “Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: Evidence from mendelian randomisation and mediation analysis”. Full results from this trial were presented at the clinical trials session at LIVES 2018 […]

Read More…

(icTV) HOT TOPICS PREVIEW ~ The ANDROMEDA shock study

(icTV) HOT TOPICS PREVIEW The ANDROMEDA shock study Glenn Hernandez (Santiago, Chile) sat down with icTV to discuss the ANDROMEDA shock study which examined peripheral perfusion targeted resuscitation in early septic shock. Results of this trial will be presented in the Hot Topics session at LIVES 2018 on Wednesday October 24th from 14:10 – 17:20 in Room Paris. Register on site […]

Read More…

The LIVES 2018 App: FREE TO DOWNLOAD NOW!

Download the LIVES 2018 App here: App Store Googleplay   This is your essential tool to fully connect to ESICM’s 31th Annual Congress LIVES 2018… GET CONNECTED NOW! […]

Read More…